CX-1739

From WikiMD's Wellness Encyclopedia

CX-1739 is a drug that has been studied for its potential use in the treatment of cognitive disorders. It acts as a GABA_A receptor positive allosteric modulator and also inhibits the GABA transporter 1 (GAT1), which may contribute to its pharmacological effects.

Pharmacology[edit | edit source]

CX-1739 is a positive allosteric modulator of the GABA_A receptor, a type of protein that responds to the neurotransmitter gamma-aminobutyric acid (GABA). By enhancing the effects of GABA at this receptor, CX-1739 may increase the inhibitory effects of this neurotransmitter, potentially leading to sedative and anxiolytic effects.

In addition to its effects on the GABA_A receptor, CX-1739 also inhibits the GABA transporter 1 (GAT1). This transporter is responsible for the reuptake of GABA from the synaptic cleft, and its inhibition by CX-1739 could lead to increased levels of GABA in the brain.

Clinical significance[edit | edit source]

CX-1739 has been studied for its potential use in the treatment of cognitive disorders. However, as of 2021, it is not currently approved for use in any country.

See also[edit | edit source]

References[edit | edit source]


CX-1739 Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD